Condition: Parkinson Disease · Healthy · Parkinsonian Syndromes · Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
The working hypotheses are as follows: #1 The processing of performance signals by automated lognormal segmentation and the extraction of the parameters of interest will make it possible to distinguish groups of patients from healthy elderly subjects. #2 The three instrumental approaches will not have the same degree of reliability as a predictive biomarker of clinical diagnosis established by consensus.
This description comes directly from the study's public registry record.
Pierre Blanchet, MD · 514-890-8123 · pierre.j.blanchet@umontreal.ca
Always discuss trial participation with your own doctor first.
| CHUM/Université de Montréal | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06161636